Global mRNA Transcriptome Sequencing Market Strategic Research Report

Scope of the Report

The global mRNA Transcriptome Sequencing market size is predicted to grow from US$ 4,922 million in 2025 to US$ 13,310 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.

In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.

Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated—giving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.

Need for new platforms for accurate RNA data interpretation and advancements made in bioinformatics, rise in cases of metabolic disorders, multiple sclerosis, and other diseases, growing demand for RNA Sequencing over the conventional technology, are factors that drive the growth of the mRNA sequencing market. In addition, increase in healthcare expenditure; partnerships & collaborations between key players to facilitate development; rise in R&D activities are factors that boost the market growth for mRNA sequencing. However, the need for skilled professionals, the huge initial capital investment on infrastructure, problems associated with the storage of sequencing data are factors that hinder the mRNA sequencing market growth.

This report presents a comprehensive overview of the global mRNA Transcriptome Sequencing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Next Generation Sequencing
• Single Molecule Sequencing
• Others

Segment by Application

• Biomedical Field
• Non-medical Field

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global mRNA Transcriptome Sequencing market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Biomedical Field, Non-medical Field evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact